Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
17.86
-0.43 (-2.32%)
At close: Jul 24, 2026, 4:00 PM EDT
17.75
-0.11 (-0.59%)
After-hours: Jul 24, 2026, 7:22 PM EDT
Quince Therapeutics Employees
Quince Therapeutics had 38 employees as of December 31, 2025. The number of employees increased by 2 or 5.56% compared to the previous year.
Employees
38
Change (1Y)
2
Growth (1Y)
5.56%
Revenue / Employee
n/a
Profits / Employee
-$951,447
Market Cap
17.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | 2 | 5.56% | 38 | 0 |
| Dec 31, 2024 | 36 | 4 | 12.50% | 36 | 0 |
| Dec 31, 2023 | 32 | 11 | 52.38% | 32 | 0 |
| Dec 31, 2022 | 21 | -34 | -61.82% | 21 | 0 |
| Dec 31, 2021 | 55 | 17 | 44.74% | 55 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Longeveron | 38 |
| Palatin Technologies | 29 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| Tevogen Bio Holdings | 18 |
| Quantum BioPharma | 17 |
| Lipocine | 14 |
QNCX News
- 24 days ago - Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board - GlobeNewsWire
- 25 days ago - Quince Therapeutics trading halted, news pending - TheFly
- 4 weeks ago - Quince Therapeutics initiated with an Outperform at Leerink - TheFly
- 4 weeks ago - Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 4 weeks ago - Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 2 months ago - UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD - GlobeNewsWire
- 2 months ago - Quince Therapeutics Transcript: Investor update - Transcripts
- 2 months ago - Quince Therapeutics Press release: Investor update - Filings